(Q35159106)

6 August 2017

1 reference

title

Medical management of biological warfare and bioterrorism: place of the immunoprevention and the immunotherapy (English)

1 reference

6 August 2017

0 references

1 reference

Patrice Binder

1

1 reference

6 August 2017

Olivier Attre

2

1 reference

6 August 2017

Jean Paul Boutin

3

1 reference

6 August 2017

Jean Didier Cavallo

4

1 reference

6 August 2017

Thierry Debord

5

1 reference

6 August 2017

Alain Jouan

6

1 reference

6 August 2017

Dominique Vidal

7

1 reference

6 August 2017

language of work or name

1 reference

1 October 2003

1 reference

Comparative Immunology, Microbiology & Infectious Diseases

6 August 2017

published in

1 reference

6 August 2017

volume

26

1 reference

6 August 2017

issue

5-6

1 reference

6 August 2017

page(s)

401-421

1 reference

Anthrax: the investigation of a deadly outbreak

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Biological warfare. A historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Inhalational anthrax: epidemiology, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Anthrax as a biological weapon, 2002: updated recommendations for management

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Tularemia as a biological weapon: medical and public health management

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Smallpox as a Biological Weapon

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

The threat of smallpox and bioterrorism

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Public health surveillance in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Passive immunity in prevention and treatment of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Antibodies for defense against biological attack.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Passive transfer of antibodies protects immunocompetent and imunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Aerosolized specific antibody protects mice from lung injury associated with aerosolized ricin exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Neutralization of streptococcal pyrogenic exotoxins and staphylococcal enterotoxins by antiserum to synthetic peptides representing conserved amino acid motifs

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Passive antibody therapies: progress and continuing challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Passive and active immunotherapy for experimental pneumococcal pneumonia by polyvalent human immunoglobulin or F(ab')2 fragments administered intranasally

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Lassa fever. Effective therapy with ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Perspectives for the treatment of infections with Flaviviridae

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Education is the key to defense against bioterrorism

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Executive summary: developing objectives, content, and competencies for the training of emergency medical technicians, emergency physicians, and emergency nurses to care for casualties resulting from nuclear, biological, or chemical incidents

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Mechanism of action of clostridial neurotoxins and rational inhibitor design

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Genetic engineering of snake toxins. The functional site of Erabutoxin a, as delineated by site-directed mutagenesis, includes variant residues

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

Viruses as gene delivery vectors: application to gene function, target validation, and assay development

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0147-9571%2803%2900023-7

1 reference

7 January 2021

10.1016/S0147-9571(03)00023-7

Identifiers

DOI

1 reference

6 August 2017

1 reference